NASDAQ:GNOM Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free GNOM Stock Alerts $9.70 +0.01 (+0.10%) (As of 09:39 AM ET) Add Compare Share Share Today's Range$9.65▼$9.7550-Day Range$9.68▼$12.2952-Week Range$8.63▼$13.33Volume12,624 shsAverage Volume69,072 shsMarket Capitalization$88.46 millionAssets Under Management$88.43 millionDividend Yield0.00%Net Expense Ratio0.50% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get Global X Genomics & Biotechnology ETF alerts: Email Address About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Read More GNOM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNOM ETF News HeadlinesApril 18, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On 10x GenomicsMarch 21, 2024 | investorplace.com3 Stocks That Could Be the Next Big Thing in Gene EditingApril 26, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…March 14, 2024 | finance.yahoo.comGlobal X Genomics & Biotechnology UCITS ETF (GNOG.L)March 6, 2024 | investing.comGlobal X Genomics & Biotechnology ETF (GNOM)December 29, 2023 | msn.comGlobal X Cannabis ETF declares $0.1656 dividendMay 12, 2023 | investing.comGlobal X S&P 500® Catholic Values ETF (CATH)April 29, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News SummaryApril 26, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…April 15, 2023 | thestreet.comComplete Genomics Stock Falls On Unusually High Volume (GNOM)See More Headlines Receive GNOM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerGlobal X Fund NameGlobal X Genomics & Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:GNOM Inception Date4/5/2019 Fund ManagerChang Kim, James Ong, Nam To, Wayne Xie Webwww.completegenomics.com Phone+1-650-9432800Fund Focus Asset ClassEquity BenchmarkSolactive Genomics Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings44 Fund Statistics Assets Under Management$90.69 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorGlobal X Management Company LLC AdvisorGlobal X Management Company LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerSusquehanna Options OptionableOptionable Options Volume1 Put Options1 Call Options1 Short Interest11,000 shs Miscellaneous Outstanding Shares9,120,000Beta1.03 Creation Unit50,000 Creation Fee$500.00 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Global X Genomics & Biotechnology ETF ExpensesTypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.48%0.51%Other Expenses0.00%0.72%0.54%0.34%0.58%Total Expense0.50%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.76%-0.55%-0.22%-0.57%Net Expense0.50%0.59%0.60%0.54%0.58% Global X Genomics & Biotechnology ETF (GNOM) Holdings & ExposureTop 10 GNOM HoldingsNatera(NASDAQ:NTRA)Holding Weight: 8.02%CRISPR Therapeutics(NASDAQ:CRSP)Holding Weight: 5.28%Moderna(NASDAQ:MRNA)Holding Weight: 4.89%Ultragenyx Pharmaceutical(NASDAQ:RARE)Holding Weight: 4.86%Agilent Technologies(NYSE:A)Holding Weight: 4.72%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 4.05%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 3.99%Qiagen(NYSE:QGEN)Holding Weight: 3.82%Illumina(NASDAQ:ILMN)Holding Weight: 3.76%Bio-Techne(NASDAQ:TECH)Holding Weight: 3.74%GNOM Sector ExposureGNOM Industry ExposureFull Holdings Details Similar ETFsValkyrie Bitcoin Miners ETFNASDAQ:WGMIWahed Dow Jones Islamic World ETFNASDAQ:UMMAWisdomTree Cybersecurity FundNASDAQ:WCBRVictoryShares THB Mid Cap ETFNASDAQ:MDCPFirst Trust Indxx Innovative Transaction & Process ETFNASDAQ:LEGRInstitutional OwnershipSightline Wealth Advisors LLCSold 1,800 shares on 4/24/2024Ownership: 0.680%Raymond James Financial Services Advisors Inc.Bought 12,342 shares on 4/23/2024Ownership: 2.887%Centaurus Financial Inc.Bought 1,624 shares on 2/26/2024Ownership: 0.155%James J. Burns & Company LLCBought 4,848 shares on 2/13/2024Ownership: 0.225%Manhattan West Asset Management LLCSold 83,405 shares on 2/12/2024Ownership: 0.460%View All Institutional Transactions GNOM ETF - Frequently Asked Questions How have GNOM shares performed in 2024? Global X Genomics & Biotechnology ETF's stock was trading at $11.56 at the beginning of 2024. Since then, GNOM shares have decreased by 16.1% and is now trading at $9.70. View the best growth stocks for 2024 here. What does GNOM invest in? Global X Genomics & Biotechnology ETF is a equity fund issued by Global X. GNOM focuses on theme investments and follows the Solactive Genomics Index. The fund's investments total to approximately $88.43 million assets under management. What stocks does Global X Genomics & Biotechnology ETF hold? GNOM invests in 44 holdings. Some of the stocks in their portfolio include Natera (NTRA), CRISPR Therapeutics (CRSP), Moderna (MRNA), Ultragenyx Pharmaceutical (RARE), Agilent Technologies (A), BioMarin Pharmaceutical (BMRN), Sarepta Therapeutics (SRPT), Qiagen (QGEN), Illumina (ILMN) and Bio-Techne (TECH). What is the management fee for Global X Genomics & Biotechnology ETF? Global X Genomics & Biotechnology ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GNOM is 0.50%. What other stocks do shareholders of Global X Genomics & Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB). Who are Global X Genomics & Biotechnology ETF's major shareholders? Global X Genomics & Biotechnology ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Raymond James Financial Services Advisors Inc. (2.89%) and Sightline Wealth Advisors LLC (0.68%). How do I buy shares of Global X Genomics & Biotechnology ETF? Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GNOM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.